Venus Concept Stock (NASDAQ: VERO) stock price, news, charts, stock research, profile.
Open | $0.800 |
Close | $0.815 |
Volume / Avg. | 15.497K / 546.601K |
Day Range | 0.760 - 0.870 |
52 Wk Range | 0.602 - 4.700 |
Market Cap | $5.080M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 0.73% |
Days to Cover | 1.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Venus Concept (NASDAQ: VERO) through any online brokerage.
Other companies in Venus Concept’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Venus Concept (NASDAQ: VERO) was reported by BTIG on Friday, October 6, 2023. The analyst firm set a price target for 0.00 expecting VERO to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Venus Concept (NASDAQ: VERO) is $0.7994 last updated April 17, 2024 at 7:10 PM EDT.
There are no upcoming dividends for Venus Concept.
Venus Concept’s Q1 earnings are confirmed for Wednesday, May 15, 2024.
There is no upcoming split for Venus Concept.
Venus Concept is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.